David Lazar agrees to invest $3.1 million in Preferred Stock and becomes Interim CEO. BERKELEY HEIGHTS, N.J., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NAS ...
On Tuesday, December 3, 2024, in Texas Top Cop Shop, the U.S. District Court for the Eastern District of Texas, Sherman ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback